Name: Latest research reports of Solara Active Pharma Sciences Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Solara Active Pharma Sciences Ltd.
Rating: 5
Author: Motilal Oswal

Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540 | ISIN: INE624Z01016 | Industry: Pharmaceuticals
| Mid-range Performer

604.4000 -37.45 (-5.83%)

NSE Aug 01, 2025 15:31 PM

31.54% Fall from 52W High

Volume: 212.5K

Solara Active Pharma Sciences Ltd.

04 Aug 2021

604.40

-5.83%

Comprehensive approach in API/CRAMS to drive growth

Buy: Solara Active Pharma Scien...

Motilal Oswal

Comprehensive approach in API/CRAMS to drive growth Motilal Oswal values your support in the Asiamoney Brokers Poll 2021 for India Research, Sales, Corporate Access and...

Solara Active Pharma Sciences Ltd. has gained 22.39% in the last 3 Months

The Baseline | 01 Aug 2025, 05:05PM

Market closes lower, Godrej Properties' revenue beats Forecaster estimates by 40% in Q1

Trendlyne Marketwatch | 01 Aug 2025, 03:57PM

Earnings Call Transcript - Q1FY21 for Solara Active Pharma Sciences

| 03 Aug 2020